Department of Neurosurgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Department of Cerebrovascular, The Affiliated Hospital of Zunyi Medical College, Zunyi, China.
CNS Neurosci Ther. 2020 Jul;26(7):698-710. doi: 10.1111/cns.13298. Epub 2020 Mar 1.
Axonal injury results in long-term neurological deficits in traumatic brain injury (TBI) patients. Apolipoprotein E (ApoE) has been reported to activate intracellular adaptor protein Disabled-1 (Dab1) phosphorylation via its interaction with ApoE receptors. The Dab1 pathway acts as a regulator of axonal outgrowth and growth cone formation in the brain.
We hypothesized that ApoE may alleviate axonal injury and regulate axonal regeneration via the Dab1 pathway after TBI.
In this study, we established a model of controlled cortical impact (CCI) to mimic TBI in vivo. Using diffusion tensor imaging to detect white matter integrity, we demonstrated that APOE-deficient mice exhibited lower fractional anisotropy (FA) values than APOE mice at 28 days after injury. The expression levels of axonal regeneration and synapse plasticity biomarkers, including growth-associated protein 43 (GAP43), postsynaptic density protein 95 (PSD-95), and synaptophysin, were also lower in APOE-deficient mice. In contrast, APOE deficiency exerted no effects on the levels of myelin basic protein (MBP) expression, oligodendrocyte number, or oligodendrocyte precursor cell number. Neurological severity score (NSS) and behavioral measurements in the rotarod, Morris water maze, and Y maze tests revealed that APOE deficiency caused worse neurological deficits in CCI mice. Furthermore, Dab1 activation downregulation by the ApoE receptor inhibitor receptor-associated protein (RAP) or Dab1 shRNA lentivirus attenuated the beneficial effects of ApoE on FA values, GAP43, PSD-95, and synaptophysin expression, and neurological function tests. Additionally, the effects of ApoE on axonal regeneration were further validated in vitro. In a mechanical scratch injury model of primary cultured neurons, recombinant ApoE protein treatment enhanced axonal outgrowth and growth cone formation in injured neurons; however, these effects were attenuated by Dab1 shRNA, consistent with the in vivo results.
Collectively, these data suggest that ApoE promotes axonal regeneration partially through the Dab1 pathway, thereby contributing to functional recovery following TBI.
外伤性脑损伤(TBI)患者的轴突损伤会导致长期的神经功能缺损。已有报道称载脂蛋白 E(ApoE)通过与 ApoE 受体的相互作用,激活细胞内衔接蛋白Disabled-1(Dab1)的磷酸化。Dab1 通路作为大脑中轴突生长和生长锥形成的调节剂。
我们假设 ApoE 可能通过 Dab1 通路减轻 TBI 后的轴突损伤并调节轴突再生。
在这项研究中,我们建立了一种皮质撞击(CCI)模型,以模拟体内的 TBI。使用弥散张量成像来检测白质完整性,我们发现 APOE 缺陷型小鼠在损伤后 28 天的各向异性分数(FA)值低于 APOE 型小鼠。轴突再生和突触可塑性生物标志物的表达水平,包括生长相关蛋白 43(GAP43)、突触后密度蛋白 95(PSD-95)和突触小体蛋白,在 APOE 缺陷型小鼠中也较低。相反,APOE 缺失对髓鞘碱性蛋白(MBP)表达、少突胶质细胞数量或少突胶质前体细胞数量没有影响。在旋转棒、Morris 水迷宫和 Y 迷宫测试中的神经严重程度评分(NSS)和行为测量显示,APOE 缺失导致 CCI 小鼠的神经功能缺损更严重。此外,ApoE 受体抑制剂受体相关蛋白(RAP)或 Dab1 shRNA 慢病毒下调 Dab1 激活,减弱了 ApoE 对 FA 值、GAP43、PSD-95 和突触小体蛋白表达以及神经功能测试的有益影响。此外,还在体外验证了 ApoE 对轴突再生的影响。在原代培养神经元的机械划痕损伤模型中,重组 ApoE 蛋白处理增强了损伤神经元的轴突生长和生长锥形成;然而,这些效应被 Dab1 shRNA 减弱,与体内结果一致。
综上所述,这些数据表明 ApoE 通过 Dab1 通路促进轴突再生,从而有助于 TBI 后的功能恢复。